Biolase Inc (BIOL): Hedge Funds In Wait-and-See Mode
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Biolase Inc (BIOL)
Get Email AlertsSector: Dental Equipment & Supplies
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 198,933 | $70 | +74% | 0% |
| 2. | Renaissance Technologies Jim Simons | 62,700 | $22 | +65% | 0% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.45 | 70,000 | Officer, Director | 621,530 | 2021-11-30 | Filing | |
| $0.61 | 35,000 | Officer, Director | 551,530 | 2021-08-20 | Filing | |
| $0.75 | 40,000 | Officer, Director | 516,530 | 2021-05-19 | Filing | |
| $57.50 | 1,843 | Large Shareholder | 1,843 | 2019-10-29 | Filing | |
| $57.50 | 2,783 | Large Shareholder | 2,783 | 2019-10-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.38 | 11,038 | Director | 633,096 | 2021-12-15 | Filing | |
| $0.55 | 10,400 | Large Shareholder | 0 | 2020-06-09 | Filing | |
| $0.55 | 47,885 | Large Shareholder | 0 | 2020-06-09 | Filing | |
| $0.55 | 79,841 | Large Shareholder | 184,300 | 2020-06-09 | Filing | |
| $0.55 | 358,744 | Large Shareholder | 264,141 | 2020-06-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 6,879,290 | $2,430 | 0% | |
| 2. | 3,066,030 | $1,083 | 0.88% | |
| 3. | 3,025,769 | $1,069 | 0% | |
| 4. | 3,000 | $1,060 | 0% | |
| 5. | 1,621,992 | $573 | 0.07% |
News See All
10 Best Dental Stocks to Buy Now
Dental health is one of the key indicators for overall health and well being. However, it is evident that the industry has been one of the most overlooked in the healthcare sector today.
Do Hedge Funds Love Biolase Inc (BIOL)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Fund and Insider Trading News: Stanley Druckenmiller, David Tepper, Constellation Pharmaceuticals Inc (CNST), BIOLASE Inc (BIOL), Novocure Ltd (NVCR), and a Lot More
The recovery in the oil industry is attracting some of the most recognized billionaires in money management.
BIOLASE Inc (BIOL): How It Stacks Up Against Its Peers
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...
Birchview Capital’s Top Healthcare Stock Picks
Birchview Capital is a Vermont-based biosciences-focused long/short equity hedge fund founded by Dr. Matthew Strobeck in 2014. Dr. Strobeck holds a Ph.D.
Larry N Feinberg, Oracle Associates Open Activist Position in BIOLASE
Larry N Feinberg, the manager of Oracle Associates, has opened a position in BIOLASE Inc (NASDAQ:BIOL). In a recent filing with the Securities and Exchange Commission, Mr.
BIOLASE Inc (BIOL) Shareholders: Have You Seen This Crucial Data?
BIOLASE Inc (NASDAQ:BIOL) was in 4 hedge funds' portfolio at the end of the fourth quarter of 2012. BIOL shareholders have witnessed a decrease in enthusiasm from smart money in recent months.
Galena Biopharma Inc (GALE), BIOLASE Inc (BIOL), Achillion Pharmaceuticals, Inc. (ACHN): Three Biotech Giants to Look For
In the world of biotech investing, there are many companies to choose from. When the market is on a riding stride, investment in more speculative stocks that have inflated valuations can get tough.
Billionaire Hedge Funds
